The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Immunomonitoring and prognostic relevance of neutrophils in clinical trials
Open accessAbstract
The clinical relevance of the interaction between human cancer and neutrophils has recently begun to emerge. This review will focus on recently published articles regarding immunomonitoring of neutrophils in blood and tumor tissue in clinical trials comprising the main human tumor types, with a strong emphasis on independent prognostic relevance assessed by multivariate analyses. The prognostic role of tumor-infiltrating neutrophils, elevated blood neutrophils and elevated blood neutrophil/lymphocyte ratio has been associated with poor clinical outcome in several human cancers, most notably in renal cell carcinoma, melanoma, colorectal cancer, hepatocellular carcinoma, cholangiocarcinoma, glioblastoma, GIST, gastric, esophageal, lung, ovarian and head and neck cancer. A striking finding is the notion that high baseline neutrophil count in either tumor or blood, or both, was identified as strong, independent risk factor for poor outcome in multivariate analyses, and the negative prognostic impact of neutrophils was not eliminated by increasing the dose of cytokines, chemotherapy, or targeted therapy. For several cancers, patients benefit most from therapy if baseline neutrophil was low. Thus, baseline neutrophils over-ride nadir counts in prognostic significance. In summary, a proportion of patients who do not experience benefit from surgery or medical intervention may be associated with a worst prognosis because they are characterized by baseline tumor-related neutrophilia protecting them from benefit from therapy. Further research to unraveling the cancer biology and new treatment options is encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Heng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
Heng, D. Y., Xie, W., Regan, M. M., Harshman, L. C., Bjarnason, G. A., Vaishampayan, U. N., Mackenzie, M., Wood, L., Donskov, F., Tan, M.-H., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70559-4 · Cited by 1,030
Self-citationCancer-related inflammation: Common themes and therapeutic opportunities
Balkwill, F. R., & Mantovani, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.005 · Cited by 685
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2099 · Cited by 479
Chua, W., Charles, K. A., Baracos, V. E., & Clarke, S. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.100 · Cited by 468
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Self-citationYamanaka, T., Matsumoto, S., Teramukai, S., Ishiwata, R., Nagai, Y., & Fukushima, M. (2007) · Oncology · doi:10.1159/000127412 · Cited by 454
Inflammation and prognosis in colorectal cancer
Klintrup, K., Mäkinen, J. M., Kauppila, S., Väre, P. O., Melkko, J., Tuominen, H., Tuppurainen, K., Mäkelä, J., Karttunen, T. J., & Mäkinen, M. J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.017 · Cited by 431
Gomez, D., Farid, S., Malik, H. Z., Young, A. L., Toogood, G. J., Lodge, J. P. A., & Prasad, K. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9552-6 · Cited by 402
Paesmans, M., Sculier, J. P., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Van Cutsem, O., Sergysels, R., & Mommen, P. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1221 · Cited by 386
Van Glabbeke, M. M., Owzar, K., Rankin, C., Simes, J., Crowley, J., & GIST Meta-analysis Group (MetaGIST) (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.10004 · Cited by 385
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
Shimada, H., Takiguchi, N., Kainuma, O., Soda, H., Ikeda, A., Cho, A., Miyazaki, A., Gunji, H., Yamamoto, H., & Nagata, M. (2010) · Gastric Cancer · doi:10.1007/s10120-010-0554-3 · Cited by 381
Dumitru, C. A., Moses, K., Trellakis, S., Lang, S., & Brandau, S. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1294-5 · Cited by 374
Zhou, S.-L., Dai, Z., Zhou, Z.-J., Wang, X.-Y., Yang, G.-H., Wang, Z., Huang, X.-W., Fan, J., & Zhou, J. (2012) · Hepatology · doi:10.1002/hep.25907 · Cited by 356
Teramukai, S., Kitano, T., Kishida, Y., Kawahara, M., Kubota, K., Komuta, K., Minato, K., Mio, T., Fujita, Y., Yonei, T., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.023 · Cited by 344
Négrier, S., Escudier, B., Gomez, F., Douillard, J.-Y., Ravaud, A., Chevreau, C., Buclon, M., Pérol, D., & Lasset, C. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf257 · Cited by 343
Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I. J., Larsen, S., Gehl, J., & von der Maase, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602702 · Cited by 329
Rao, H.-L., Chen, J.-W., Li, M., Xiao, Y.-B., Fu, J., Zeng, Y.-X., Cai, M.-Y., & Xie, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030806 · Cited by 327
Sharaiha, R. Z., Halazun, K. J., Mirza, F., Port, J. L., Lee, P. C., Neugut, A. I., Altorki, N. K., & Abrams, J. A. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1754-8 · Cited by 325
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
Donskov, F., & von der Maase, H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9594 · Cited by 299
Self-citationJensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2012) · Cancer · doi:10.1002/cncr.26511 · Cited by 281
Self-citationTrellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281
Van Glabbeke, M., Verweij, J., Casali, P. G., Le Cesne, A., Hohenberger, P., Ray-Coquard, I., Schlemmer, M., van Oosterom, A. T., Goldstein, D., Sciot, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.601 · Cited by 280
Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
Li, Y.-W., Qiu, S.-J., Fan, J., Zhou, J., Gao, Q., Xiao, Y.-S., & Xu, Y.-F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.044 · Cited by 268
Jung, M. R., Park, Y. K., Jeong, O., Seon, J. W., Ryu, S. Y., Kim, D. Y., & Kim, Y. J. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21986 · Cited by 251
How to calculate the dose of chemotherapy
Gurney, H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600139 · Cited by 251
Di Maio, M., Gridelli, C., Gallo, C., Shepherd, F., Piantedosi, F. V., Cigolari, S., Manzione, L., Illiano, A., Barbera, S., Robbiati, S. F., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70255-2 · Cited by 234
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue
Nielsen, H. J., Hansen, U., Christensen, I. J., Reimert, C. M., Br�nner, N., Moesgaard, F., & The RANX05 Study Group (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199912)189:4<487::aid-path484>3.0.co;2-i · Cited by 233
Bellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bernaudin, J., Mayaud, C. M., Milleron, B. J., Baud, L., & Cadranel, J. L. (1998) · PubMed Central · Cited by 228
Choueiri, T. K., Garcia, J. A., Elson, P., Khasawneh, M., Usman, S., Golshayan, A. R., Baz, R. C., Wood, L., Rini, B. I., & Bukowski, R. M. (2007) · Cancer · doi:10.1002/cncr.22827 · Cited by 228
Neutrophil infiltration into human gliomas
Fossati, G., Ricevuti, G., Edwards, S. W., Walker, C., Dalton, A., & Rossi, M. L. (1999) · Acta Neuropathologica · doi:10.1007/s004010051093 · Cited by 227
Ohno, Y., Nakashima, J., Ohori, M., Hatano, T., & Tachibana, M. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.05.028 · Cited by 217
Keizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M. A., Pili, R., Hammers, H., & Carducci, M. A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.001 · Cited by 213
He, J., Shen, G., Ren, Z., Qin, H., Cui, C., Zhang, Y., Zeng, Y., & Jia, W. (2012) · Head & Neck · doi:10.1002/hed.22008 · Cited by 201
Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., & Inferrera, C. (2002) · Modern Pathology · doi:10.1097/01.mp.0000020391.98998.6b · Cited by 194
Schmidt, H., Suciu, S., Punt, C. J. A., Gore, M., Kruit, W., Patel, P., Lienard, D., von der Maase, H., Eggermont, A. M. M., & Keilholz, U. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0274 · Cited by 190
Ilie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coëlle, C., Mouroux, J., & Hofman, P. (2012) · Cancer · doi:10.1002/cncr.26456 · Cited by 179
Gao, Q., Zhao, Y.-J., Wang, X.-Y., Qiu, S.-J., Shi, Y.-H., Sun, J., Yi, Y., Shi, J.-Y., Shi, G.-M., Ding, Z.-B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4032 · Cited by 174
Sato, H., Tsubosa, Y., & Kawano, T. (2012) · World Journal of Surgery · doi:10.1007/s00268-011-1411-1 · Cited by 172
Protumor and antitumor functions of neutrophil granulocytes
Brandau, S., Dumitru, C. A., & Lang, S. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0344-6 · Cited by 158
The Prognostic Value of Tumor-Infiltrating Neutrophils in Gastric Adenocarcinoma after Resection
Zhao, J., Pan, K., Wang, W. T., Chen, J.-G., Wu, Y., Lv, L. L., Li, J. J., Chen, Y.-B., Wang, D., Pan, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033655 · Cited by 149
Nagtegaal, I. D., Marijnen, C. A. M., Kranenbarg, E. M., Mulder-Stapel, A. A., Hermans, J., van de Velde, C. J., & van Krieken, J. H. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-7 · Cited by 139
Coley toxins immunotherapy: a retrospective review.
Richardson, M. A., Ramirez, T., Russell, N. C., & Moyé, L. A. (1999) · PubMed · Cited by 121
Gu, F., Gao, Q., Shi, G., Zhang, X., Wang, J., Jiang, J.-H., Wang, X., Shi, Y.-H., Ding, Z., Fan, J., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2268-8 · Cited by 115
Atai, N. A., Bansal, M., Lo, C., Bosman, J., Tigchelaar, W., Bosch, K. S., Jonker, A., Hamer, P. C. D. W., Troost, D., McCulloch, C. A., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03335.x · Cited by 97
Souto, J. C., Vila, L., & Brú, A. (2009) · Medicinal Research Reviews · doi:10.1002/med.20185 · Cited by 90
Kaneko, M., Nozawa, H., Sasaki, K., Hongo, K., Hiyoshi, M., Tada, N., Murono, K., Nirei, T., Kawai, K., Sunami, E., et al. (2012) · Oncology · doi:10.1159/000337228 · Cited by 81
Donskov, F. N., Hokland, M., Marcussen, N., Madsen, H. H. T., & von der Maase, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602937 · Cited by 72
Self-citationBlood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor
Perez, D. R., Baser, R. E., Cavnar, M. J., Balachandran, V. P., Antonescu, C. R., Tap, W. D., Strong, V. E. M., Brennan, M. F., Coit, D. G., Singer, S., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2682-y · Cited by 69
Banerjee, S. N., Rustin, G. J. S., Paul, J., Williams, C., Pledge, S., Gabra, H., Skailes, G., Lamont, A., Hindley, A. C., Goss, G., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds494 · Cited by 51
Rutkowski, P. L., Nowecki, Z. I., Dêbiec‐Rychter, M., Grzesiakowska, U., Michej, W., Woźniak, A., SIEDLECKI, J. A., Limon, J., Dobosz, A. J. V., Kąkol, M., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0202-4 · Cited by 43
Donskov, F. N., Bennedsgaard, K. M., Hokland, M., Marcussen, N., Fisker, R. V., Madsen, H. H. T., Fode, K., & von der Maase, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0525-9 · Cited by 42
Self-citationZhang, Y., Peng, Z., Chen, M., et al. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2011.654374 · Cited by 40
Maione, P., Rossi, A., Maïo, M. D., & Gridelli, C. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.02.022 · Cited by 31
Çetin, B., Ma, K., Berk, V., Ozturk, S. C., Beneklı, M., Işıkdoğan, A., Özkan, M., Çoşkun, U., & Buyukberber, S. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.1059 · Cited by 30
Donskov, F. N., Middleton, M. R., Fode, K., Meldgaard, P., Mansoor, W., Lawrance, J., Thatcher, N., Nellemann, H. M., & von der Maase, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602768 · Cited by 28
Self-citationInterleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
Donskov, F. N. (2007) · PubMed · Cited by 25
Self-citation
Cited by
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Wculek, S. K., & Malanchi, I. (2015) · Nature · doi:10.1038/nature16140 · Cited by 1,003
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Zhou, S.-L., Zhou, Z.-J., Hu, Z.-Q., Huang, X.-W., Wang, Z., Chen, E.-B., Fan, J., Cao, Y., Dai, Z., & Zhou, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.040 · Cited by 852
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Kim, J., & Bae, J.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/6058147 · Cited by 802
Metadata
- Authors
- Donskov, F.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 23
- Issue
- 3
- Pages
- 200-207
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W1991365889
- Cited by
- 293
- References
- 59
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.